Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07776626 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase I Exploratory Study of YOLT-203 in Patients With Primary Hyperoxaluria Type 1 (PH1)

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a single-arm, open-label, single-dose dose-escalation study. It aims to evaluate the safety and tolerability of YOLT-203 in Chinese patients with Primary Hyperoxaluria Type 1 (PH1), and to preliminarily assess the effect of a single administration of YOLT-203 on 24-hour urinary oxalate excretion. The clinical trial will first evaluate the safety and tolerability in adult patients. After the safety profile is preliminarily confirmed, the trial will be sequentially conducted in adolescents, older children, and younger children.
Trial Details
NCT Number NCT07776626
Lead Sponsor YolTech Therapeutics Co., Ltd
Collaborators: RenJi Hospital
Conditions
(from sponsor)		 Primary Hyperoxaluria Type 1, PH1
Related terms Hyperoxaluria, Hyperoxaluria, Primary, Kidney Calculi, Primary hyperoxaluria type 1
Enrollment 9 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov